Provision of unapproved medicines for unmet medical needs
We unite science, talent and technology to get ahead of disease together.
We recognise that there may be instances when Healthcare Professionals seek an unapproved medicine or vaccine for a patient that has no other satisfactory alternative treatment options. GSK has established programs that may provide an option for providers faced with these challenges.
Provision of unapproved medicines under these circumstances may be referred to by various names depending country regulations (e.g. single patient use, named patient use, compassionate use, expanded access, special access, managed access, importation of unlicensed medicine, etc.).
